Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation

Peptides

Volumn 31, Issue 8, 2010, Pages 1517-1522

  Hilaire, Rose Claire ^a   Murthya, Subramanyam N ^a   Kadowitza, Philip J ^a   Jeter Jr , James R ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Proliferation; Vasoactive intestinal peptide; VPAC1; VPAC2

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CYCLIC AMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE[6-28];

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; RAT; SMOOTH MUSCLE FIBER;

RATTUS;

EID: 78049468118     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.04.024     Document Type: Article

References (18)

1. Chattergoon NN, D'Souza FM, Deng W, Chen H, Hyman AL, Kadowitz PJ, et al. Antiproliferative effects of calcitonin gene-related peptide in aortic and pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2005; 288(1):L202-11.
2. Dickson L, Aramori I, Sharkey J, Finlayson K. VIP and PACAP receptor pharmacology: a comparison of intracellular signaling pathways. Ann N Y Acad Sci 2006; 1070:239-242
3. Ganz P, Sandrock AW, Landis SC, Leopold J, Gimbrone Jr MA, Alexander RW. Vasoactive intestinal peptide: vasodilation and cyclic AMP generation. Am J Physiol 1986; 250(5):755-760
4. Gourlet P, De Neef P, Cnudde J. In vitro properties of high affinity selective antagonists of the VIP1 receptor. Peptides 1997; 18:1555-1560
5. Harmar AJ, Sheward WJ, Morrison CF, Waser B, Gugger M, Reubi JC. Distribution of the VPAC2 receptor in peripheral tissues of the mouse. Endocrinology 2004; 145(2):1203-1210
6. Igarashi H, Ito T, Mantey SA, Pradhan TK, Hou W, Coy DH, et al. Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors. J Pharmacol Exp Ther 2005; 315(1): 370-381
7. Juarranz MG, Rampelbergh JV, Gourlet P, De Neef P, Cnudde J, Robberecht P, et al. Vasoactive intestinal polypeptide VPAC1 and VPAC2 receptor chimeras identify domains responsible for the specificity of ligand binding and activation. Eur J Biochem 1999; 265:449-456
8. Laburthe M, Couvineau A. Molecular pharmacology and structure of VPAC receptors for VIP and PACAP. Regul Pept 2002; 108:165-173
9. Laburthe M, Couvineau A, Marie JC. VPAC receptors for VIP and PACAP. Recep Channels 2002; 8:131-153
10. Maruno K, Absood A, Said SI. VIP inhibits basal and histamine-stimulated proliferation of airway smooth muscle cells. Am J Physiol 1995; 268:L1047-51.
11. Miyata A, Sato K, Hino J, Tamakawa H, Matsuo H, Kangawa K. Rat aortic smoothmuscle cell proliferation is bidirectionally regulated in a cell cycle-dependent manner via PACAP/VIP type 2 receptor. Ann N Y Acad Sci 1999:73-81.
12. Moroo I, Tatsuno I, Uchida D, Tanaka T, Saito J, Saito Y, et al. Pituitary adenylate cyclase activating peptide (PACAP) stimulates mitogen-activated protein (MAPK) in cultured rat astrocytes. Brain Res 1998; 795:191-196
13. Petkov V, Mosgoeller W, Ziesche R, Raderer M, Stiebellehner L, Vonbank K, et al. Vasoactive intestinal peptide as anewdrug for treatment of primary pulmonary hypertension. J Clin Invest 2003; 111(9):1339-1346
14. Said SI, Hamidi SA, Dickman KG, Szema AM, Lyubsky S, Lin RZ, et al. Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene. Circulation 2007; 115(10):1260-1268
15. Schulz S, Rocken C, Mawrin C, Weise W, Volker H, Schulz S. Immunocytochemical Identification of VPAC1, VPAC2 and PAC1 receptors in normal and neoplastic human tissues with the subtype-specific antibodies. Clin Cancer Res 2004 Dec; 10:8235-8242
16. St. Hilaire RC, Kadowitz PJ, Jeter Jr JR. Adenoviral transfer of vasoactive intestinal peptide (VIP) gene inhibits rat aortic and pulmonary artery smooth muscle cell proliferation. Peptides 2009; 30(12):2323-2329
17. Strosberg AD, Nahmias C. G-protein-coupled receptor signaling through protein networks. Biochem Soc Trans 2007; 35:23-27
18. Ulrich II CD, Holtmann M, Miller LJ. Secretin and Vasoactive intestinal peptide receptors: members of a unique family of G-protein-Coupled receptors. Gastroenterology 1998; 114:382-397